Allogeneic hematopoietic stem cell transplantation for isolated and leukemic myeloid sarcoma in adults: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation

Myeloid sarcoma (MS), also known as granulocytic sarcoma or chloroma, is a rare extramedullary tumor composed of immature myeloid cells at different stages of differentiation which can involve any site of the body. Most cases of myeloid sarcoma will develop within the first year preceding the

[1]  F. Lo‐Coco,et al.  Modern approaches to treating acute promyelocytic leukemia. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  F. Ferrara,et al.  Autologous stem cell transplantation for patients with acute promyelocytic leukemia in second molecular remission. , 2010, Anticancer research.

[3]  A. Lebeau,et al.  Immunohistochemistry and molecular analyses in myeloid sarcoma of the breast in a patient with relapse of NPM1-mutated and FLT3-mutated AML after allogeneic stem cell transplantation , 2010, Journal of Clinical Pathology.

[4]  F. Lo Coco,et al.  Promyelocytic Sarcoma of the Spine: A Case Report and Review of the Literature , 2010, Advances in hematology.

[5]  Bob Löwenberg,et al.  Review Articles (434 articles) , 2008 .

[6]  S. Pileri,et al.  Myeloid sarcoma: extramedullary manifestation of myeloid disorders. , 2009, American journal of clinical pathology.

[7]  E. Estey,et al.  Effective treatment of acute promyelocytic leukemia with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  C. Volteau,et al.  Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TC. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  E. Estey,et al.  Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. , 2009, Blood.

[10]  E. Estey,et al.  Myeloid sarcoma is associated with superior event‐free survival and overall survival compared with acute myeloid leukemia , 2008, Cancer.

[11]  S. Pileri,et al.  Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas , 2007, Leukemia.

[12]  S. Pileri,et al.  Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients , 2007, Leukemia.

[13]  H. Dombret,et al.  Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  E. Estey,et al.  Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy , 2003, Leukemia.

[15]  K. Yamauchi,et al.  Comparison in treatments of nonleukemic granulocytic sarcoma , 2002, Cancer.

[16]  J. Byrd,et al.  Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  S. Pileri,et al.  Extramedullary Manifestation of Myeloid Disorders , 2009 .